Neurotech International (ASX: NTI)

Neurotech International (ASX: NTI) is a medical device and solutions company operating through its wholly-owned subsidiary AAT Research Limited. Through flagship device Mente Autism and its associated platform, Neurotech is focused on the development and commercialisation of technological solutions for the diagnosis and treatment of such conditions, starting with autism. www.neurotechinternational.com

Neurotech ASX NTI cannabis treat autism epilepsy ADHD Dolce Cann strain

Neurotech to treat autism, epilepsy and ADHD using Dolce Cann’s proprietary cannabis strains

Neurotech International (ASX: NTI) has collared an exclusive global licence to use Dolce Cann Global’s cannabis strains to treat autism, epileps...
Neurotech International ASX NTI virtual mente clinic

Neurotech launches pilot virtual clinic for autism patients and their carers

Medical solutions developer Neurotech International (ASX: NTI) has launched a pilot version of a virtual clinic which enables doctors to interac...
Neurotech International ASX NTI Mente Autism trial successful

Neurotech International reports positive results in autism clinical trial

Perth-based medical solutions company Neurotech International (ASX: NTI) has confirmed its Mente Autism device specifically developed for childr...
Neurotech International ASX NTI autism effects growing number children

Neurotech on course to alleviate autism effects for growing number of children

Medical solutions developer Neurotech International (ASX: NTI) has received an academia-fuelled boost for its ‘Mente Autism’ device, designed to...
Neurotech International autism research results NTI

Neurotech International reports ‘excellent’ early findings for autism research

Perth-based Neurotech International (ASX: NTI) has surfaced from a trading halt with news of “excellent preliminary findings” for its Mente Auti...
Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2020 Small Caps. All rights reserved.